|
SESN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53488333154428E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.9100502269871E-12 |
| Normal-vs-Stage2 |
1.06920028386526E-11 |
| Normal-vs-Stage3 |
2.73336908662714E-13 |
| Normal-vs-Stage4 |
2.07456274381457E-12 |
| Stage1-vs-Stage2 |
6.926600E-01 |
| Stage1-vs-Stage3 |
8.983500E-02 |
| Stage1-vs-Stage4 |
1.176810E-01 |
| Stage2-vs-Stage3 |
3.880800E-01 |
| Stage2-vs-Stage4 |
3.551800E-01 |
| Stage3-vs-Stage4 |
8.634600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.41411360188704E-12 |
| Normal-vs-AfricanAmerican |
1.53048000000044E-05 |
| Normal-vs-Asian |
2.33368879776208E-13 |
| Caucasian-vs-AfricanAmerican |
4.410800E-01 |
| Caucasian-vs-Asian |
9.764200E-02 |
| AfricanAmerican-vs-Asian |
1.907000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.39062111720523E-13 |
| Normal-vs-Female |
3.37518901716294E-12 |
| Male-vs-Female |
1.445580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.9360519811853E-12 |
| Normal-vs-Age(41-60Yrs) |
1.48436818392383E-12 |
| Normal-vs-Age(61-80Yrs) |
2.1449508835758E-13 |
| Normal-vs-Age(81-100Yrs) |
7.3932999999915E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.318600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.133210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.411000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.923800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.933400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.938400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.798770E-01 |
| Classical-VS-Follicular |
5.376300E-02 |
| Classical-VS-Other |
1.949820E-01 |
| Classical-VS-Normal |
1.81159531820185E-11 |
| Tall-VS-Follicular |
9.349200E-01 |
| Tall-VS-Other |
5.197000E-01 |
| Tall-VS-Normal |
1.10349507309593E-11 |
| Follicular-VS-Other |
5.229000E-01 |
| Follicular-VS-Normal |
2.22333262911434E-12 |
| Other-VS-Normal |
4.38239999844825E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.17625917287023E-12 |
| Normal-vs-N1 |
2.08399963952388E-12 |
| N0-vs-N1 |
7.191400E-01 |
|
|
